Analysts think MBIO stock price could increase by 2944%
Aug 01, 2024, 6:27 AM
-18.38%
What does MBIO do
Mustang Bio, Inc., a clinical-stage biopharmaceutical company based in Worcester, Massachusetts, focuses on developing cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. The company collaborates with notable centers like City of Hope and Fred Hutchinson Cancer Center to advance CAR T therapies targeting specific antigens in different cancers.
3 analysts think MBIO stock price will increase by 2943.87%. The current median analyst target is $10.20 compared to a current stock price of $0.34. The lowest analysts target is $10.10 and the highest analyst target is $10.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.